Literature DB >> 20834042

Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration.

Raja Mita1, Michael J Beaulieu, Catherine Field, Roseline Godbout.   

Abstract

Malignant gliomas (MG) are highly infiltrative tumors that consistently recur despite aggressive treatment. Brain fatty acid-binding protein (FABP7), which binds docosahexaenoic acid (DHA) and arachidonic acid (AA), localizes to sites of tumor infiltration and is associated with a poor prognosis in MG. Manipulation of FABP7 expression in MG cell lines affects cell migration, suggesting a role for FABP7 in tumor infiltration and recurrence. Here, we show that DHA inhibits and AA stimulates migration in an FABP7-dependent manner in U87 MG cells. We demonstrate that DHA binds to and sequesters FABP7 to the nucleus, resulting in decreased cell migration. This anti-migratory effect is partially dependent on peroxisome proliferator-activated receptor γ, a DHA-activated transcription factor. Conversely, AA-bound FABP7 stimulates cell migration by activating cyclooxygenase-2 and reducing peroxisome proliferator-activated receptor γ levels. Our data provide mechanistic insight as to why FABP7 is associated with a poor prognosis in MG and suggest that relative levels of DHA and AA in the tumor environment can make a profound impact on tumor growth properties. We propose that FABP7 and its fatty acid ligands may be key therapeutic targets for controlling the dissemination of MG cells within the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20834042      PMCID: PMC2978629          DOI: 10.1074/jbc.M110.170076

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4.

Authors:  Stephen D Ayers; Katherine L Nedrow; Richard E Gillilan; Noa Noy
Journal:  Biochemistry       Date:  2007-05-22       Impact factor: 3.162

2.  Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice.

Authors:  J M Connolly; E M Gilhooly; D P Rose
Journal:  Nutr Cancer       Date:  1999       Impact factor: 2.900

3.  NMR and gas chromatography studies of lyophilized human brain tumors.

Authors:  Ryszard Marszałek; Maciej Pisklak; Wiesław Jankowski; Jacek Łukaszkiewicz; Dariusz Horsztyński; Iwona Wawer
Journal:  Acta Pol Pharm       Date:  2010 Mar-Apr       Impact factor: 0.330

4.  Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma.

Authors:  Barbara Seliger; Rudolf Lichtenfels; Derek Atkins; Jürgen Bukur; Thomas Halder; Michael Kersten; Alois Harder; Angelika Ackermann; Barbara Malenica; Walburgis Brenner; Monica Zobawa; Friedrich Lottspeich
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

5.  Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.

Authors:  H Poirier; I Niot; M C Monnot; O Braissant; C Meunier-Durmort; P Costet; T Pineau; W Wahli; T M Willson; P Besnard
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 6.  The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants.

Authors:  M A Crawford; I Golfetto; K Ghebremeskel; Y Min; T Moodley; L Poston; A Phylactos; S Cunnane; W Schmidt
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

7.  Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells.

Authors:  Hongyun Yan; Abdenaim Kermouni; Mohammed Abdel-Hafez; David C W Lau
Journal:  J Lipid Res       Date:  2002-11-04       Impact factor: 5.922

8.  Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids.

Authors:  Anannya Banga; Resat Unal; Preeti Tripathi; Irina Pokrovskaya; Randall J Owens; Philip A Kern; Gouri Ranganathan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-16       Impact factor: 4.310

9.  The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.

Authors:  H Zhang; E A Rakha; G R Ball; I Spiteri; M Aleskandarany; E C Paish; D G Powe; R D Macmillan; C Caldas; I O Ellis; A R Green
Journal:  Breast Cancer Res Treat       Date:  2009-07-10       Impact factor: 4.872

10.  Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.

Authors:  Yu Liang; Andrew W Bollen; Ken D Aldape; Nalin Gupta
Journal:  BMC Cancer       Date:  2006-04-19       Impact factor: 4.430

View more
  39 in total

1.  Time of day regulates subcellular trafficking, tripartite synaptic localization, and polyadenylation of the astrocytic Fabp7 mRNA.

Authors:  Jason R Gerstner; William M Vanderheyden; Timothy LaVaute; Cara J Westmark; Labib Rouhana; Allan I Pack; Marv Wickens; Charles F Landry
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

2.  Effects of nuclear factor I phosphorylation on calpastatin (CAST) gene variant expression and subcellular distribution in malignant glioma cells.

Authors:  The Minh Vo; Rebecca Burchett; Miranda Brun; Elizabeth A Monckton; Ho-Yin Poon; Roseline Godbout
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

3.  Effects of Docosahexaenoic Acid in Preventing Experimental Choroidal Neovascularization in Rodents.

Authors:  Sara Moghaddam-Taaheri; Monica Agarwal; Juan Amaral; Irina Fedorova; Elvira Agrón; Norman Salem; Emily Chew; S Patricia Becerra
Journal:  J Clin Exp Ophthalmol       Date:  2011-10-23

4.  Amyloid-β induces sleep fragmentation that is rescued by fatty acid binding proteins in Drosophila.

Authors:  Jason R Gerstner; Olivia Lenz; William M Vanderheyden; May T Chan; Cory Pfeiffenberger; Allan I Pack
Journal:  J Neurosci Res       Date:  2016-06-19       Impact factor: 4.164

5.  Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-α signaling.

Authors:  Soke Chee Kwong; Amira Hajirah Abd Jamil; Anthony Rhodes; Nur Aishah Taib; Ivy Chung
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

6.  Distinct isoform of FABP7 revealed by screening for retroelement-activated genes in diffuse large B-cell lymphoma.

Authors:  Frances E Lock; Rita Rebollo; Katharine Miceli-Royer; Liane Gagnier; Sabrina Kuah; Artem Babaian; Maialen Sistiaga-Poveda; C Benjamin Lai; Oksana Nemirovsky; Isabel Serrano; Christian Steidl; Mohammad M Karimi; Dixie L Mager
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

7.  Calcineurin regulates nuclear factor I dephosphorylation and activity in malignant glioma cell lines.

Authors:  Miranda Brun; Darryl D Glubrecht; Shairaz Baksh; Roseline Godbout
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

8.  Fasting enriches liver triacylglycerol with n-3 polyunsaturated fatty acids: implications for understanding the adipose-liver axis in serum docosahexaenoic acid regulation.

Authors:  Kristin A Marks; Phillip M Marvyn; Juan J A Henao; Ryan M Bradley; Ken D Stark; Robin E Duncan
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

9.  Fatty acid binding proteins have the potential to channel dietary fatty acids into enterocyte nuclei.

Authors:  Adriana Esteves; Anja Knoll-Gellida; Lucia Canclini; Maria Cecilia Silvarrey; Michèle André; Patrick J Babin
Journal:  J Lipid Res       Date:  2015-12-11       Impact factor: 5.922

Review 10.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.